Transvenous ICD Implantation into a Coronary Sinus Branch: A Safe and Feasible Alternative to Deliver ICD after Tricuspid Valve Reconstruction

M Gruszczynski; A Müller-Burri; A Häussler; A Breitenstein; H Rodriguez Cetina Biefer; O Dzemali

doi:10.1155/2023/6646224

Transvenous ICD Implantation into a Coronary Sinus Branch: A Safe and Feasible Alternative to Deliver ICD after Tricuspid Valve Reconstruction

Case Rep Cardiol. 2023 Feb 8:2023:6646224. doi: 10.1155/2023/6646224. eCollection 2023.

Authors

M Gruszczynski¹, A Müller-Burri², A Häussler¹, A Breitenstein^{3

4}, H Rodriguez Cetina Biefer¹, O Dzemali^{1

3

4}

Affiliations

¹ Department for Cardiac Surgery, Zurich City Hospital Triemli, Zurich, Switzerland.
² Department for Cardiology, Zurich City Hospital, Zurich, Switzerland.
³ Department for Cardiac Surgery, University Hospital Zurich, Zurich, Switzerland.
⁴ Department for Cardiology, University Hospital Zurich, Zurich, Switzerland.

Abstract

Significant lead-induced tricuspid regurgitation after cardiovascular implantable electronic devices is not uncommon. Absolute or relative contraindications to place the lead in the right ventricle after tricuspid valve (TV) surgery still remains a challenge. We report about successful lead extraction followed by transvenous implantable cardioverter defibrillator lead placement in the side branches of coronary sinus after TV reconstruction. Furthermore, we discuss therapeutic options to deliver concomitant anti-bradycardia therapy, technical pitfalls, and surgical approaches.

Publication types

Case Reports